Clinical Trial Update: Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care

View source ↗

Summary

A clinical trial sponsored by Imperial College London aims to evaluate blood biomarkers to enable early and accurate diagnosis of Alzheimer's disease in primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Imperial College London | Conditions: Alzheimer Disease, Biomarkers / Blood | Status: NOT_YET_RECRUITING